Search
Search Results
-
Retention rates and reasons for non-retention in exercise oncology trials in the post-treatment phase—a systematic review
PurposeRetention is a key marker of trial success. Poor retention can induce bias, reduce statistical power and minimise the validity of trials. This...
-
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study
BackgroundThis study examined associations between receipt of hepatitis C (HCV) treatment and retention in office-based opioid treatment (OBOT) care.
... -
Workforce Diversity and disparities in wait time and retention among opioid treatment programs
BackgroundWorkforce diversity is a key strategy to improve treatment engagement among members of racial and ethnic minority groups. In this study, we...
-
Spatial and Environmental Correlates of Prevalence of Treatment for Substance Use Disorders, Retention, and SUD Services Utilization in South Sardinia
This study explored the economic, social, and spatial correlates of treatment prevalence, retention, and service utilization for substance use...
-
Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus
Introduction/objectivesThe ASCORE study on treatment for rheumatoid arthritis (RA) showed better retention and clinical response rates for abatacept...
-
The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a sco** review
BackgroundAn emerging public health threat of methamphetamine/opioid co-use is occurring in North America, including increases in overdoses related...
-
Factors influencing female engagement, retention and completion of substance abuse treatment: a systematic review
AimThis systematic review aimed to summarise the factors influencing women’s engagement with, retention in and completion of substance abuse...
-
Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study
BackgroundMedications for opioid use disorder (MOUD) are associated with positive health outcomes. People remaining on MOUD have a reduced likelihood...
-
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use
BackgroundWe use a novel, longitudinal approach to describe average time spent in opioid use disorder (OUD) cascade of care stages for people with...
-
Clinical observation of pressing-kneading manipulation combined with herb-insulated moxibustion at Shuidao (ST28) in the treatment of postpartum urinary retention after labor analgesia
ObjectiveTo observe the clinical efficacy of pressing-kneading manipulation combined with herb-insulated moxibustion at Shuidao (ST28) for postpartum...
-
Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study
ObjectivesTo evaluate the outcomes of adalimumab (ADA) treatment of patients with non-infectious uveitis and scleritis, focusing on efficacy,...
-
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities
BackgroundThough methadone has been shown to effectively treat opioid use disorder, many barriers prevent individuals from accessing and maintaining...
-
Assessing the impact of public funding in alleviating participant reduction and improving the retention rate in methadone maintenance treatment clinics in Taiwan: an interrupted time series analysis
BackgroundGiven the steady decline in patient numbers at methadone maintenance treatment (MMT) clinics in Taiwan since 2013, the government...
-
Protective Factor Predictors of Abstinence and Retention in Patients Receiving Methadone Treatment for Opioid Use Disorder
Methadone maintenance treatment (MMT) is an evidence-based intervention for opioid use disorder (OUD). Despite its effectiveness, drug use during...
-
Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
IntroductionGolimumab, a monoclonal antibody against tumor necrosis factor–α (TNF-α), is used widely for treatment of rheumatic diseases. Long-term...
-
DRD2 TaqIA polymorphism-related functional connectivity between anterior insula and dorsolateral prefrontal cortex predicts the retention time in heroin-dependent individuals under methadone maintenance treatment
BackgroundDopamine receptor D2 (DRD2) TaqIA polymorphism has an influence on addiction treatment response and prognosis by mediating brain...
-
Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention
BackgroundDuring the COVID pandemic, overall buprenorphine treatment appeared to remain relatively stable, despite some studies suggesting a decrease...
-
“Sometimes you have to take the person and show them how”: adapting behavioral activation for peer recovery specialist-delivery to improve methadone treatment retention
BackgroundDespite efficacy of medication for opioid use disorder, low-income, ethno-racial minoritized populations often experience poor opioid use...
-
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
BackgroundThe last decade has shown a remarkable increase in the rates of illicit opioid use in Canada and internationally, which is associated with...
-
Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer
PurposeDepression is among the most common comorbid psychiatric disorders of patients with breast cancer. Depression decreases patient quality of...
